This Saturday, June 21, 2014, Seyfarth attorney, Justin K. Beyer, will present at the 19th Annual Chinese Biopharmaceutical Association Conference on Legal Challenges in Trade Secret Protection, at the University of Maryland’s Shady Grove Conference Center. Through this panel discussion, Mr. Beyer will offer insights into what constitutes a trade secret, trade secrets unique to the pharmaceutical industry, and best
Continue Reading Seyfarth Attorney to Present on Protecting Pharmaceutical Trade Secrets at the Chinese Biopharmaceutical Association’s Annual Meeting
Enforcing Non-Compete Agreements in the Pharmaceutical Industry
Employee mobility in the pharmaceutical industry is a significant concern for employers given the industry’s very significant investment in and reliance upon generating and protecting confidential, proprietary and trade secret information that is used to develop products and create and maintain customer relationships.
Non-competition and customer non-solicitation agreements are one of the primary tools available in most states to protect
Continue Reading Enforcing Non-Compete Agreements in the Pharmaceutical Industry
2013 Trade Secrets Webinar Series – Year in Review
Throughout 2013, Seyfarth Shaw LLP’s dedicated Trade Secrets, Computer Fraud & Non-Competes Practice Group hosted a series of CLE webinars that addressed significant issues facing clients today in this important and ever changing area of law.
The series consisted of twelve webinars:
1. 2012 National Year in Review: What You Need to Know About the Recent Cases/Developments in Trade Secrets,
Continue Reading 2013 Trade Secrets Webinar Series – Year in Review
Upcoming Webinar: Trade Secrets in the Pharmaceutical Industry
On October 29, 2013, at 12:00 p.m. Central, Chicago Seyfarth attorneys Shashank Upadhye, Scott Schaefers, and Justin Beyer will present the tenth installment in our 2013 Trade Secrets webinar series, focusing on trade secrets in the pharmaceutical industry.
The topics they will cover include:
- Defining and understanding trade secrets in the pharmaceutical market, including the “hidden” trade secrets involved in
Continue Reading Upcoming Webinar: Trade Secrets in the Pharmaceutical Industry
North Carolina Federal District Court Confirms Importance of Alleging Actual Harm in Pleadings
On April 25, 2012, a federal judge in North Carolina issued a ruling granting in part and denying in part motions to dismiss involving claims for trade secret misappropriation, breach of contract, and conversion in a dispute between two pharmaceutical companies in the case of River’s Edge Pharmaceuticals v. Gorbec Pharmaceutical Services, Inc. This decision confirms, to an extent, the need to